First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday
U.S. stocks mixed; First Tracks Biotherapeutics surged 18% on positive celiac trial results, while C3.ai, Liquidia and others also gained.
Crypto · News reference
Maxim Group Maintains Buy on American Bitcoin, Raises Price Target to $16
Maxim Group analyst Matthew Garland maintains American Bitcoin (NASDAQ:ABTC) with a Buy and raises the price target from $15 to $16.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
HC Wainwright & Co. Assumes American Bitcoin at Buy, Announces Price Target of $22
HC Wainwright & Co. analyst Mike Colonnese assumes American Bitcoin (NASDAQ:ABTC) with a Buy rating and announces Price Target of $22.
Shares of crypto-linked companies are trading lower amid a drop in Bitcoin after rising yields, a stronger dollar and ongoing conflict in the Middle East cool risk appetite.